Literature DB >> 29806708

The role of Pdcd4 in tumour suppression and protein translation.

Qing Wang1, Hsin-Sheng Yang1,2.   

Abstract

Programmed cell death 4 (Pdcd4), a tumour suppressor, is frequently down-regulated in various types of cancer. Pdcd4 has been demonstrated to efficiently suppress tumour promotion, progression and proliferation. The biochemical function of Pdcd4 is a protein translation inhibitor. Although the fact that Pdcd4 inhibits protein translation has been known for more than a decade, the mechanism by which Pdcd4 controls tumorigenesis through translational regulation of its target genes is still not fully understood. Recent studies show that Pdcd4 inhibits translation of stress-activated-protein kinase interacting protein 1 to suppress tumour invasion, depicting a picture of how Pdcd4 inhibits tumorigenesis through translational inhibition. Thus, understanding the mechanism of how Pdcd4 attenuates tumorigenesis by translational control should provide a new strategy for combating cancer.
© 2018 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Proliferation; Tumour invasion; Tumour promotion; eIF4A

Year:  2018        PMID: 29806708      PMCID: PMC6261700          DOI: 10.1111/boc.201800014

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  71 in total

1.  Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice.

Authors:  Hua Jin; Tae Hee Kim; Soon-Kyung Hwang; Seung-Hee Chang; Hyun Woo Kim; Hanjo K Anderson; Han-Woong Lee; Kee-Ho Lee; Nancy H Colburn; Hsin-Sheng Yang; Myung-Haing Cho; Chong Su Cho
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

Review 2.  eIF4E expression in tumors: its possible role in progression of malignancies.

Authors:  A De Benedetti; A L Harris
Journal:  Int J Biochem Cell Biol       Date:  1999-01       Impact factor: 5.085

3.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 4.  Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.

Authors:  F Blasi
Journal:  Bioessays       Date:  1993-02       Impact factor: 4.345

5.  Suppression of PDCD4 mediated by the long non-coding RNA HOTAIR inhibits the proliferation and invasion of glioma cells.

Authors:  Yong'An Chen; Yusong Bian; Shanpeng Zhao; Fanqiang Kong; Xin'Gang Li
Journal:  Oncol Lett       Date:  2016-10-27       Impact factor: 2.967

6.  Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.

Authors:  René Nieves-Alicea; Nancy H Colburn; Ann-Marie Simeone; Ana M Tari
Journal:  Breast Cancer Res Treat       Date:  2008-04-04       Impact factor: 4.872

7.  Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.

Authors:  Q Wang; Z Sun; H-S Yang
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

8.  Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.

Authors:  Binhua P Zhou; Jiong Deng; Weiya Xia; Jihong Xu; Yan M Li; Mehmet Gunduz; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2004-09-26       Impact factor: 28.824

9.  Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.

Authors:  L Azzoni; O Zatsepina; B Abebe; I M Bennett; P Kanakaraj; B Perussia
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.

Authors:  Q Wang; J Zhu; Y-W Wang; Y Dai; Y-L Wang; C Wang; J Liu; A Baker; N H Colburn; H-S Yang
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

View more
  22 in total

Review 1.  Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

Review 2.  The Translational Regulation in mTOR Pathway.

Authors:  Miaomiao Yang; Yanming Lu; Weilan Piao; Hua Jin
Journal:  Biomolecules       Date:  2022-06-08

Review 3.  Dissecting the Roles of PDCD4 in Breast Cancer.

Authors:  Qian Cai; Hsin-Sheng Yang; Yi-Chen Li; Jiang Zhu
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

Review 4.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

5.  PDCD4 limits prooncogenic neuregulin-ErbB signaling.

Authors:  Juan Carlos Montero; Atanasio Pandiella
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

6.  Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.

Authors:  Chaogang Yang; Rongzhang Dou; Chen Wei; Keshu Liu; Dongdong Shi; Chunxiao Zhang; Qing Liu; Shuyi Wang; Bin Xiong
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 12.910

7.  B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells.

Authors:  Joe Taylor; Sarah Wilmore; Sophie Marriot; Karly-Rai Rogers-Broadway; Rachel Fell; Annabel R Minton; Tom Branch; Meg Ashton-Key; Mark Coldwell; Freda K Stevenson; Francesco Forconi; Andrew J Steele; Graham Packham; Alison Yeomans
Journal:  Cell Signal       Date:  2022-03-16       Impact factor: 4.850

Review 8.  Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Alicja Forma; Amr Maani; Elżbieta Sitarz; Mansur Rahnama-Hezavah; Elżbieta Radzikowska; Piero Portincasa
Journal:  Cells       Date:  2020-04-23       Impact factor: 6.600

9.  CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.

Authors:  Janeen H Trembley; Bin Li; Betsy T Kren; Amy A Gravely; Emiro Caicedo-Granados; Mark A Klein; Khalil Ahmed
Journal:  Biomedicines       Date:  2021-05-18

10.  PDCD4 deficiency ameliorates left ventricular remodeling and insulin resistance in a rat model of type 2 diabetic cardiomyopathy.

Authors:  Jie Zhang; Meng Zhang; Zhi Yang; Shanying Huang; Xiao Wu; Lei Cao; Xiaohong Wang; Qian Li; Na Li; Fei Gao
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.